Premphase 14 / 14 (conjugated estrogens / medroxyprogesterone) Drug Interactions
A total of 318 drugs (1152 brand and generic names) are known to interact with Premphase 14 / 14 (conjugated estrogens / medroxyprogesterone).
- 26 major drug interactions (67 brand and generic names)
- 264 moderate drug interactions (998 brand and generic names)
- 28 minor drug interactions (87 brand and generic names)
Check for interactions with Premphase 14 / 14 (conjugated estrogens / medroxyprogesterone)
Common medications checked in combination with Premphase 14 / 14 (conjugated estrogens / medroxyprogesterone)
- alprazolam
- cetirizine
- dextromethorphan / guaifenesin
- diclofenac
- hydrocodone / ibuprofen
- levothyroxine
- methimazole
- omeprazole
- pseudoephedrine
- venlafaxine
- Wellbutrin XL (bupropion)
Premphase 14 / 14 (conjugated estrogens / medroxyprogesterone) alcohol/food Interactions
There are 6 alcohol/food interactions with Premphase 14 / 14 (conjugated estrogens / medroxyprogesterone)
Premphase 14 / 14 (conjugated estrogens / medroxyprogesterone) disease Interactions
There are 25 disease interactions with Premphase 14 / 14 (conjugated estrogens / medroxyprogesterone) which include:
- Abnormal Genital Bleeding
- Abnormal Vaginal Bleeding
- Carcinomas (Estrogenic)
- Hypercalcemia In Breast Cancer
- Hypertension
- Thromboembolism/Cardiovascular
- Hepatic Neoplasms
- Menstrual Bleeding
- Breast Malignancy
- Liver Disease
- Thromboembolism
- Angioedema
- Gallbladder Disease
- Hypercalcemia
- Hyperlipidemia
- Liver Disease
- Melasma
- Depression
- Fluid Retention
- Glucose Intolerance
- Retinal Thrombosis
- Thyroid Function Tests
- Bone Mineral Density
- Hyperlipidemia
- Weight Gain
More about Premphase 14/14 (conjugated estrogens / medroxyprogesterone)
- Premphase 14/14 Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Drug class: sex hormone combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No information available. |
Do not stop taking any medications without consulting your healthcare provider.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
